| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $6.60M | $9.76M | $11.73M | $11.04M | $5.69M |
| R&D | $2.70M | $4.81M | $6.47M | $5.34M | $3.39M |
| SG&A | $3.90M | $4.95M | $5.26M | $5.71M | $2.30M |
| Operating Income | -$6.60M | -$9.76M | -$11.73M | -$11.04M | -$5.69M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$6.53M | -$8.91M | -$11.65M | -$8.48M | -$5.53M |
| EPS (basic) | – | – | -0.6400 | -0.4700 | -0.3700 |
| EPS (diluted) | -0.3300 | -0.4900 | -0.6400 | – | – |
| Shares (diluted) | $19.71M | $18.27M | $18.22M | – | – |